Genomic Valley Biotech share news, announcements and annual reports
BSE: 539206Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹45.81.
30 Oct: open ₹48.10, high ₹48.10, low ₹48.00
- Under BSE's graded surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 9,359
Genomic Valley Biotech share news and announcements
492 announcements, routine notices left out, newest first. Page 10 of 10.
Apr 2017
6 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
Feb 2017
Jan 2017
7 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
4 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Dec 2016
Nov 2016
Oct 2016
16 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
6 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Sep 2016
Aug 2016
4 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 04, 2016, inter alia, has considered and approved the following: ....
Jul 2016
18 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
10 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Jun 2016
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has considered and approved the following: - ....
Apr 2016
30 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 29, 2016, inter alia, has considered and approved the following: ....21 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
14 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Feb 2016
9 Feb · Change in Company Secretary & Compliance officer
Board of Directors at its meeting held on February 09, 2016, inter alia, has considered and approved the resignation of Mr. Rohit Batham, ....
Jan 2016
23 Jan · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....16 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
11 Jan · Authorised KMPs to determine materiality of events/information
11 Jan · Limited Review Report for Dec 31, 2015
11 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 11, 2016, inter alia, has considered and approved the following: ....
Nov 2015
Oct 2015
Sep 2015
Aug 2015
7 Aug · Board meeting
Board of Directors of the Company at its August 07, 2015, inter alia, has considered and approved the following: - Taken note ....7 Aug · Extension of time for holding 21st A G M
Company had applied for extension of Annual General Meeting for the financial year 2014-15 from Registrar of Companies and they had ....
Jul 2015
10 Jul · Shareholding Pattern For March 31, 2015
10 Jul · Listing of equity shares of Genomic Valley Biotech Ltd
Trading Members of the Exchange are hereby informed that effective from July 10, 2015, the equity shares of Genomic Valley Biotech Ltd (Scrip Code: 539206) are listed and admitted to dealings ....